LSV Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.3M Sell
951,000
-2,319,015
-71% -$45.7M 0.04% 322
2025
Q4
$61.9M Sell
3,270,015
-348,900
-10% -$6.47M 0.14% 196
2025
Q3
$67.5M Sell
3,618,915
-153,400
-4% -$2.87M 0.15% 181
2025
Q2
$69.6M Sell
3,772,315
-486,500
-11% -$8.63M 0.16% 171
2025
Q1
$74.4M Sell
4,258,815
-22,700
-0.5% -$383K 0.18% 151
2024
Q4
$74.2M Sell
4,281,515
-69,600
-2% -$1.27M 0.17% 161
2024
Q3
$81M Sell
4,351,115
-29,700
-0.7% -$501K 0.17% 158
2024
Q2
$67.5M Buy
4,380,815
+104,800
+2% +$1.5M 0.15% 178
2024
Q1
$63.2M Sell
4,276,015
-109,600
-2% -$1.52M 0.13% 196
2023
Q4
$62.6M Buy
4,385,615
+107,266
+3% +$1.52M 0.14% 198
2023
Q3
$59.6M Buy
4,278,349
+37,100
+0.9% +$475K 0.14% 194
2023
Q2
$49.9M Sell
4,241,249
-163,500
-4% -$1.86M 0.11% 215
2023
Q1
$50.7M Sell
4,404,749
-214,740
-5% -$2.66M 0.11% 205
2022
Q4
$57.4M Sell
4,619,489
-154,960
-3% -$1.98M 0.13% 194
2022
Q3
$62.6M Sell
4,774,449
-227,970
-5% -$3.37M 0.15% 174
2022
Q2
$69.9M Buy
5,002,419
+1,000
+0% +$13.4K 0.15% 171
2022
Q1
$74.5M Sell
5,001,419
-15,400
-0.3% -$211K 0.14% 187
2021
Q4
$67.9M Sell
5,016,819
-252,799
-5% -$3.58M 0.12% 200
2021
Q3
$77.6M Buy
5,269,618
+288,486
+6% +$4.87M 0.14% 187
2021
Q2
$90.7M Buy
4,981,132
+35,500
+0.7% +$632K 0.15% 176
2021
Q1
$85.9M Buy
4,945,632
+983,836
+25% +$17.3M 0.15% 185
2020
Q4
$68.8M Buy
3,961,796
+86,334
+2% +$1.38M 0.13% 202
2020
Q3
$53.4M Buy
3,875,462
+272,482
+8% +$4M 0.11% 214
2020
Q2
$52M Sell
3,602,980
-140,900
-4% -$1.85M 0.11% 216
2020
Q1
$40.9M Sell
3,743,880
-96,400
-3% -$1.78M 0.1% 209
2019
Q4
$82M Buy
3,840,280
+94,422
+3% +$2.11M 0.13% 190
2019
Q3
$86M Sell
3,745,858
-191,643
-5% -$4.09M 0.14% 182
2019
Q2
$77.5M Buy
3,937,501
+69,021
+2% +$1.34M 0.12% 193
2019
Q1
$75.3M Sell
3,868,480
-69,700
-2% -$1.32M 0.12% 196
2018
Q4
$64.9M Sell
3,938,180
-58,816
-1% -$1.18M 0.12% 194
2018
Q3
$92.4M Buy
3,996,996
+383,100
+11% +$8.68M 0.14% 182
2018
Q2
$78.5M Buy
3,613,896
+351,516
+11% +$6.87M 0.12% 198
2018
Q1
$57.6M Buy
3,262,380
+7,869
+0.2% +$139K 0.09% 225
2017
Q4
$61.1M Sell
3,254,511
-53,200
-2% -$1.06M 0.1% 223
2017
Q3
$72.6M Buy
3,307,711
+287,775
+10% +$6.5M 0.12% 199
2017
Q2
$72.8M Buy
3,019,936
+241,022
+9% +$6.13M 0.13% 187
2017
Q1
$77.6M Buy
2,778,914
+868,441
+45% +$22.8M 0.14% 171
2016
Q4
$46.7M Buy
1,910,473
+1,153,464
+152% +$26.4M 0.09% 238
2016
Q3
$19.1M Buy
757,009
+635,913
+525% +$15.2M 0.04% 330
2016
Q2
$2.5M Buy
121,096
+5,000
+4% +$104K 0.01% 644
2016
Q1
$2.33M Buy
+116,096
New +$2.23M ﹤0.01% 633

Other funds holding SBRA

LSV Asset Management's SBRA Position: Q1 2026 in Review

LSV Asset Management reduced its Sabra Healthcare REIT (SBRA) stake by 71% in Q1 2026, selling an estimated $45.7M and leaving 951,000 shares worth $18.3M. The position accounts for 0.04% of the portfolio, ranked #322.

LSV Asset Management first reported a position in SBRA in Q1 2016 and has held it in 41 quarters since. The position peaked at $92.4M in Q3 2018. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • LSV Asset Management held 951,000 shares of Sabra Healthcare REIT worth $18.3M as of Q1 2026.
  • LSV Asset Management sold 2,319,015 Sabra Healthcare REIT shares in Q1 2026, an estimated $45.7M.
  • Sabra Healthcare REIT made up 0.04% of LSV Asset Management's portfolio in Q1 2026, its #322 holding.
  • LSV Asset Management first reported a position in Sabra Healthcare REIT in Q1 2016 and has held it in 41 quarters since.
  • LSV Asset Management's Sabra Healthcare REIT position peaked at $92.4M in Q3 2018.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on LSV Asset Management's 13F filing for Q1 2026, filed 11 May 2026.